Dr. Christina Charbonneau of Bullhead City, AZ
is ranked among the top physicians in the nation based on patient reviews.
BULLHEAD CITY, Ariz.
April 3, 2013
/PRNewswire-USNewswire/ -- Patients' Choice has announced that Dr.
was one of a select few physicians honored with the prestigious 2012
Compassionate Doctor Certification.
Each year, nearly 100 million patients across the U.S. access websites like
to provide feedback about experiences with their physicians.
Only those physicians with near perfect overall and bedside manner scores, as voted by their patients, are selected for the Compassionate Doctor recognition. Of the nation's 870,000 active physicians, only 3% were accorded this honor in 2012.
The Compassionate Doctor certification is part of the Patients' Choice recognition program, where patients rate and vote for their favorite doctors.
commented on the recognition: "This is quite an honor for me. I am very pleased to have been selected and grateful to my patients who went out of their way to rate me and give me positive reviews."
a short profile by and about the honoree:
is an award-winning doctor who has been practicing medicine for more than 30 years. She is also a certified coach, media personality, speaker and former medical school professor as well as a fellow in Integrative Medicine at the
University of Arizona
College of Medicine with Dr.
. She is also a #1 international best-selling author with her contribution to the book, Ready Aim Captivate!: Put Magic in Your Message and A Fortune in Your Future.
For more information on this
, please visit Dr.
profile on Vitals.com
Following the publication of Dr.
selection for the
Patients' Choice Award
, American Registry seconded the honor and added Dr. Goldstein-Charbonneau to The Registry™ of Business Excellence. An exclusive recognition plaque has been designed to commemorate the honor. The doctor's custom wall plaque is
For more information on Dr.
, located in
call 928-704-4949, or visit
This press release was written by American Registry, LLC with approval by and/or contributions from Dr. Goldstein-Charbonneau and was distributed by PR Newswire, a subsidiary of UBM plc.